Patient involvement in prostate cancer treatment decisions.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29028

Enrollment

300

Registered

2005-07-06

Start date

2001-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention group is usual care plus decision aid (150 patients). Control group is usual care (150 patients), not receiving a decision aid.

Eligibility

Inclusion criteria

Inclusion criteria: Patients with prostate cancer referred for radiotherapy with curative intent are eligible.

Exclusion criteria

Exclusion criteria: Labile personality structure, as assessed by the physicians, and lack of understanding of the Dutch language.

Design outcomes

Primary

Measure	Time frame
Primary outcome measure is choice acceptance. At the end of the interview, the patient is asked whether he wants to choose one of the two treatment options, or whether he wants to leave the decision to the physician. The response to this question is choice acceptance. Choice acceptance is confirmed by telephone 2 days later. This measure is obtained about 10 days after the first consultation.	—

Secondary

Measure	Time frame
1. Substitute preferences of physicians, 2. quality of life measures, 3. decision evaluation measures, 4. coping measures, 5. knowledge measures, 6. treatment preferences.	—

Contacts

Public ContactP.F.M. Stalmeier

University Medical Center St. Radboud, Department of Radiotherapy, Geert Grooteplein 14A Room 0.10

p.stalmeier@mta.umcn.nl+31 (0)24 3610592

Outcome results